Protokylol

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C18H21NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Y5Y4EEO2V, chemically known as 1-(3,4-dihydroxyphenyl)-2-(alpha-methyl-3,4-methylendioxyphenethylamino)ethanol but generally known as protokylol, which bears US NIH Compound Identifier 4969. European Medicines Agency schedules Protokylol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10144MIG. The term PROTOKYLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PROTOKYLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule protokylol under HS 29329970 and SITC 51569. As of Q4 2014, PROTOKYLOL remains the US FDA Preferred Term for this commodity. Protokylol bears US NLM identifiers UMLS ID C0163026 and NCI Concept Code C74198. SMILES: OC(CNC(CC1CC2OCOC2CC1)C)C1CC(O)C(O)CC1.